CLINICAL ASPECTS OF AZOOSPERMIA: A REVIEW
Journal Title: Journal of Drug Discovery and Therapeutics - Year 2013, Vol 1, Issue 2
Abstract
Infertility is defined as the failure of a couple to become pregnant after one year of regular, unprotected, sexual intercourse. Infertility is not "just a female problem" as there is a male infertility component in approximately 50% of couples. Azoospermia, defined as complete absence of sperm from the ejaculate, is present in about 1% of all men and in approximately 15% of infertile men. Azoospermia may occur because of reproductive tract obstruction (obstructive azoospermia) or inadequate production of spermatozoa, such that spermatozoa do not appear in the ejaculate (non-obstructive azoospermia). This review includes causes of azoospermia, symptoms of azoospermia, diagnosis of azoospermia, evaluation of azoospermia and treatment of azoospermia.
Authors and Affiliations
Prof. Satyanand Tyagi*| President & Founder, Tyagi Pharmacy Association (TPA) & Scientific Writer (Pharmacy), Chattarpur, New Delhi, India-110074, Anil Kumar Gupta| Research Scholar, Bhagwant University, Institute of Pharmacy & Research Center, Ajmer, Rajasthan, India-305004, Dr. Kamlesh Garg| Department of Pharmacology, VMMC and Safdarjung Hospital, New Delhi, India-110029, Patel Chirag J| Department of Pharmaceutics, Maharishi Arvind Institute of Pharmacy, Mansarovar, Jaipur, Rajasthan, India-302020, Mangukia Dhruv| Department of Pharmaceutics, Maharishi Arvind Institute of Pharmacy, Mansarovar, Jaipur, Rajasthan, India-302020, Yadav Praveen| Department of Pharmaceutics, Maharishi Arvind Institute of Pharmacy, Mansarovar, Jaipur, Rajasthan, India-302020, Divya Bharti| Department of Anatomy, Bhojia Dental College and Hospital, Nalagarh Road, Budh, Baddi, Himachal Pradesh, India-173205
Keywords
Related Articles
- EP ID EP1347
- DOI -
- Views 787
- Downloads 54
A review on oral dispersible tablet
It has been reported that about 40% of the compounds being developed by the pharmaceutical industries are poorly water soluble. The limiting factor to the in vivo performance of poorly water soluble drugs after oral admi...
TREATMENT AND MANAGEMENT OF DIABETES WITH STEM CELL THERAPY: A NEWER SCIENTIFIC APPRAOCH
Diabetes is usually a lifelong (chronic) disease in which there are high levels of sugar in the blood. Diabetes, often referred to by doctors as diabetes mellitus, describes a group of metabolic diseases in which the per...
FORMULATION AND EVALUATION OF RIFAMPICIN SOLID LIPID NANOPARTICLES
The solid lipid nanoparticles (SLNs) are sub-micron sized colloidal carriers composed of physiological lipid dispersed either in water or in an aqueous surfactant solution. SLNs as colloidal drug carrier combine the adv...
PHOSPHOLIPASE A2 IN AIRWAY DISEASES: TARGET FOR DRUG DISCOVERY
Importance of the Field: Inflammatory airway diseases are on the rise world over. There is need for orally active, safe and efficacious antiinflammatory agent. Existing therapeutic options are plagued by poor efficacy an...
AN OVERVIEW OF EMERGING PHARMACOLOGICAL TARGETS IN TREATMENT OF TYPE 2 DIABETES MELLITUS
Diabetes is a chronic disorder which has serious complications if not treated appropriately. A number of therapeutic agents exist for the treatment of type 2 diabetes including metformin, sulfonylureas, thiazolidinedion...